The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 54 , ISSUE 1 ( January-March, 2012 ) > List of Articles


Decoding Population Genetics: Impact on Tuberculosis Control and Treatment

Mridula Bose

Citation Information : Bose M. Decoding Population Genetics: Impact on Tuberculosis Control and Treatment. Indian J Chest Dis Allied Sci 2012; 54 (1):5-7.

DOI: 10.5005/ijcdas-54-1-5

License: CC BY-NC 4.0

Published Online: 16-06-2022

Copyright Statement:  Copyright © 2012; The Author(s).


PDF Share
  1. Moller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis 2010;90:71-83.
  2. Motulsky AG. Metabolic polymorphism and the role of infectious diseases in human evolution. Hum Biol 1960;32:28-62.
  3. Database SNP. Available at:
  4. Hapmap database. Available at:
  5. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978;117:621-4.
  6. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990;322:422-7.
  7. Doffinger R, Dupuis S, Picard C, Fieschi C, Feinberg J, Barcenas-Morales G, et al. Inherited disorders of IL-12 and IFN-gamma-mediated immunity: a molecular genetics update. Mol Immunol 2002;38:903-9.
  8. Moller M, de Wit E, Hoal EG. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 2010;58:3-26.
  9. Yim JJ, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology 2010;15:241-56.
  10. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Metaanalyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years’ research. Am J Respir Crit Care Med 2009;180:618-31.
  11. Haukim N, Bidwell JL, Smith AJP, Keen LJ, Gallagher G, Kimberly R, et al. Cytokine gene polymorphism in human disease: on-line databases. Gen Immun 2002;3:(Suppl. 2): 313-30.
  12. Indian Genome Variation Consortium. Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet 2008;87:3-20.
  13. Yim JJ, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology 2010;15:241-56.
  14. Abhimanyu, Mangangcha IR, Jha P, Arora K, Mukerji M, Banavaliker JN, et al. Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis. Infect Genet Evol 2011;11:1015-22.
  15. Abhimanyu, Consortium IGV, Jha P, Bose M. Footprints of genetic susceptibility to tuberculosis: cytokine gene variants in north Indians. Indian J Med Res 2011. (In Press)
  16. Abhimanyu, Jha P, Jain A, Arora K, Bose M. Genetic association study suggests a role of SP110 polymorphism in lymph node tuberculosis but not pulmonary tuberculosis in north Indians. Hum Immunol 2011;72:576-80.
  17. Chu CT, Jacoby JJ, Herbst RS. Future directions of monoclonal antibody use in personalized lung cancer therapy. Oncology 2010;24:1-4.
  18. Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, et al. Five siRNAs targeting three SNPs may provide therapy for three-quarters of huntington's disease patients. Curr Biol 2009;19:774-8.
  19. Barnes PF. Immunotherapy for tuberculosis: waves of the future or tilting at the windmills. Am J Respir Crit Care Med 2003;168:142-3.
  20. Augustynowicz-Kopeæ E, Zwolska Z, Niemirowska-Mikulska H. Bioavailability of isoniazid in healthy volunteers—fast and slow INH acetylators. Pneumonol Alergol Pol 2002;70:167-79.
  21. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, Clark SL. Population stratification confounds genetic association studies among Latinos. Hum Genet 2006;118:652-64.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.